Through a series of concise, expert-led talks, we’ll explore practical approaches to achieving stability across pharmaceutical development, manufacturing, and lifecycle management. Whether you're navigating early-stage formulation or optimizing long-term product performance, this event offers actionable insights and real-world solutions. Stay for the joint discussion to engage with peers, ask questions, and spark new ideas.
Evonne Brennan, Consultant, Evonne Brennan Consulting
Evonne Brennan is a seasoned pharmaceutical consultant with over two decades of experience in technical product management, formulation development, and strategic leadership across global markets. She is the Co-Founder of LifeSci Innovations Ltd. and previously co-founded Atam Health Limited, driving innovation in health and life sciences. Evonne spent 18 years at IMCD Group, where she held roles including Technical Director for the Americas and International Technical Marketing Manager, supporting clients across Europe, Africa, and the U.S. Her expertise spans formulation troubleshooting, technical training, and project management for leading pharmaceutical ingredients. She holds a Master’s in Pharmaceutical Manufacturing and Process Technology and a Higher Diploma in Science from Technological University Dublin, where she also serves as a Selection Board Member and former Associate Lecturer. Evonne is passionate about advancing pharmaceutical science through education, collaboration, and innovation.
John LaMattina, Scientist, Author and Speaker
John L. LaMattina is the former Senior Vice President of Pfizer Inc. and President of Pfizer Global Research and Development, where he led over 13,000 scientists across the U.S., Europe, and Asia. Over his 30-year career at Pfizer, he advanced from medicinal chemist to senior leadership roles, contributing to the development of treatments for cancer, AIDS, rheumatoid arthritis, and smoking cessation. John earned a B.S. in Chemistry from Boston College and a Ph.D. in Organic Chemistry from the University of New Hampshire, followed by postdoctoral research at Princeton University. He holds numerous U.S. patents and has published extensively in scientific literature.
He is the author of Drug Truths and Devalued and Distrusted, and a contributor to Forbes. His accolades include the ACS Earle Barnes Award, the Equal Opportunity Award from Legal Momentum, and honorary degrees from Boston College and UNH.
LaMattina serves on the boards of PureTech Health, Ligand Pharmaceuticals, Immunome, and Vedanta, and is active in community foundations. He lives in Stonington, Connecticut, with his wife Mary, and has three children.
